Cytokinetics Inc (CYTK)
54.70
-1.26
(-2.25%)
USD |
NASDAQ |
Nov 14, 16:00
54.71
+0.01
(+0.02%)
Pre-Market: 20:00
Cytokinetics Cash from Operations (Quarterly): -101.50M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -101.50M |
| June 30, 2024 | -99.31M |
| March 31, 2024 | -129.51M |
| December 31, 2023 | -74.04M |
| September 30, 2023 | -96.20M |
| June 30, 2023 | -121.80M |
| March 31, 2023 | -122.29M |
| December 31, 2022 | -98.19M |
| September 30, 2022 | -84.04M |
| June 30, 2022 | -90.48M |
| March 31, 2022 | -26.81M |
| December 31, 2021 | -44.74M |
| September 30, 2021 | -38.77M |
| June 30, 2021 | -29.50M |
| March 31, 2021 | -29.52M |
| December 31, 2020 | 52.15M |
| September 30, 2020 | 14.37M |
| June 30, 2020 | -27.44M |
| March 31, 2020 | -30.14M |
| December 31, 2019 | -19.06M |
| September 30, 2019 | -20.27M |
| June 30, 2019 | -24.68M |
| March 31, 2019 | -26.91M |
| December 31, 2018 | -12.33M |
| September 30, 2018 | -32.24M |
| Date | Value |
|---|---|
| June 30, 2018 | -26.85M |
| March 31, 2018 | -29.81M |
| December 31, 2017 | -24.07M |
| September 30, 2017 | -25.48M |
| June 30, 2017 | -31.26M |
| March 31, 2017 | -20.94M |
| December 31, 2016 | 77.83M |
| September 30, 2016 | -12.12M |
| June 30, 2016 | -11.22M |
| March 31, 2016 | -17.51M |
| December 31, 2015 | -9.942M |
| September 30, 2015 | -10.35M |
| June 30, 2015 | -9.187M |
| March 31, 2015 | 34.36M |
| December 31, 2014 | -8.13M |
| September 30, 2014 | -9.515M |
| June 30, 2014 | -9.376M |
| March 31, 2014 | -17.82M |
| December 31, 2013 | -12.43M |
| September 30, 2013 | 10.31M |
| June 30, 2013 | 6.624M |
| March 31, 2013 | -12.22M |
| December 31, 2012 | -7.124M |
| September 30, 2012 | -8.878M |
| June 30, 2012 | -8.699M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-129.51M
Minimum
Mar 2024
52.15M
Maximum
Dec 2020
-59.84M
Average
-59.39M
Median
Cash from Operations (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 43.71M |
| Biomarin Pharmaceutical Inc | 221.48M |
| Catalyst Pharmaceuticals Inc | 72.87M |
| Sarepta Therapeutics Inc | -70.70M |
| Ocugen Inc | -9.911M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -45.05M |
| Cash from Financing (Quarterly) | 3.425M |
| Free Cash Flow | -407.05M |
| Free Cash Flow Per Share (Quarterly) | -0.8684 |
| Free Cash Flow to Equity (Quarterly) | -103.27M |
| Free Cash Flow Yield | -6.96% |